3′,5′-cyclic phosphate prodrugs for HCV infection
US9296778B2 · kind B2 · utility
18Cited by
137References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 21, 2013 |
| Grant date | Mar 29, 2016 |
| Priority date | — |
| Expiry date | Jun 29, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/213
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.